ANALOGUE HIN47 OF HAEMOPHILUS WITH REDUCED PROTEASE ACTIVITY Russian patent published in 2003 - IPC

Abstract RU 2196176 C2

FIELD: immunology, microbiology, genetic and protein engineering. SUBSTANCE: invention relates to immunogens and antigens of Haemophilus species. Isolated and purified analogue of Hin47 protein from Haemophilus influenzae exhibits decreased protease activity that is less 10% of activity of natural protein Hin47 but the same immunogenic properties as natural protein due to substitution or incorporation of at least one amino acid in native protein determining protease activity. Amino acid can be taken among amino acids 195-201, His-91 or Asp- 121 of native protein Hin47. Chimeric molecule comprises analogue of protein Hin47 of Haemophilus influenzae bound with polysaccharide. Recombinant plasmid DS-1011-1-1 (pT7/Hin47*) carries nucleic acid molecule expressing analogue of protein Hin47 with substitution of Ser-197 for alanine. At least a single amino acid residue of protein Hin47 determining protease activity is identified. For removal or substitution of nucleotide sequence encoding this amino acid site-directed mutagenesis of gene hin47 is carried out. Mutant gene is incorporated into cell to obtain transformed cell and the latter is cultured to yield analogue of Hin47. Immunogenic composition comprises effective amount of analogue Hin47. Interaction of sample with analogue Hin47 is carried out to obtain complexes comprising analogue Hin47 and recognizing its antibodies specifically if they present in sample. In subject immunization antibodies exhibiting specificity to protein Hin47 are obtained. Interaction of sample with antibodies is carried out. Diagnostic set for assay of antibodies presence that are able to recognize protein Hin47 specifically comprises in sample analogue of protein Hin47 and agents providing interaction of analogue with sample. Invention ensures to obtain vaccine preparations against sicknesses caused by pathogenic microorganism Haemophilus influenzae. EFFECT: improved method of preparing, valuable biological and medicinal properties. 18 cl, 25 dwg, 3 tbl, 14 ex

Similar patents RU2196176C2

Title Year Author Number
PURIFIED AND ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT PLASMID, RECOMBINANT VECTOR, PURIFIED AND ISOLATED PROTEIN, PURIFIED AND ISOLATED PROTEIN D15 OR ITS PART OF EXTERNAL ENVELOPE, SYNTHETIC PEPTIDE, CHIMERIC MOLECULE, IMMUNOGENIC COMPOSITION AND ANTISERUM OR ANTIBODY 1993
  • Pele Chong
  • Vejn Tomas
  • Jan-Ping Jang
  • Shina Lusmore
  • Du Juan Charlz Sia
  • Majkl Klejn
RU2141528C1
DNA FRAGMENT ENCODING TRANSFERRIN RECEPTOR PROTEIN FRAGMENT OF STRAIN HAEMOPHILUS (VARIANTS), PLASMID VECTOR (VARIANTS), RECOMBINANT PROTEIN (VARIANTS), ISOLATED AND PURIFIED PROTEIN (VARIANTS), IMMUNOGENIC COMPOSITION AND METHOD OF ISOLATION AND PURIFICATION OF PROTEIN 1994
  • Luzmor Shina
  • Kharkness Robin
  • Shriverz Ehntoni
  • Chong Pele
  • Grej-Ouehn Skott
  • Jang Jan-Ping
  • Merdin Ehndrju
  • Klejn Majkl
RU2194757C2
SYNTHETIC PEPTIDE, SYNTHETIC LIPOPEPTIDE, IMMUNOGENIC CONJUGATE (VARIANTS), METHOD OF OLIGOMER PREPARING, POLYSACCHARIDE PROTECTED BY SOLID POLYETHYLENE GLYCOL MONOMETHYL ESTER 1993
  • Pele Chong
  • Ali Kandil
  • Charl'Z Saja
  • Majkl Kh.Klejn
RU2141527C1
GENES ENCODING MORAXELLA TRANSFERRIN RECEPTOR 1997
  • Majers Lajza E.
  • Shrivers Ehntoni B.
  • Khehrkness Robin E.
  • Lusmor Shina M.
  • Du Ran-Pehn
  • Jang Jan-Ping
  • Klajn Majkl Kh.
RU2235128C2
METHOD OF ISOLATION AND PURIFICATION OF PROTEIN OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE, STRAIN MORAXELLA CATARRHALIS FOR PREPARING PROTEIN CD, ISOLATED AND PURIFIED NONDENATURATED PROTEIN CD OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE AND IMMUNOGENIC COMPOSITION COMPRISING PROTEIN CD OF MORAXELLA CATARRHALIS EXTERNAL MEMBRANE 1995
  • Jang Jan-Ping
  • Khakness Robin E.
  • Majers Liza E.
  • Makginness Ursula
  • Klejn Majkl Kh.
RU2186582C2
HYBRID PROTEIN, HYBRID GENE, METHOD OF PREPARING A HYBRID PROTEIN, VACCINE AGAINST UPPER RESPIRATORY WAY VIRAL DISEASE, BACULOVIRAL EXPRESSION VECTOR (VARIANTS) 1993
  • Mishel Kh.Klejn
  • Run-Pan Du
  • Meri E.Ehvazishin
RU2123047C1
POLYVALENT ASSOCIATED DIPHTHERIA, TETANUS TOXOIDS AND PERTUSSIS POLIOVIRUS VACCINES 1997
  • Fakhim Raafat E.F.
  • Tehn Lehrri Ju.L.
  • Barreto L'Juis
  • Tippkhavong Dzhon
  • Dzhekson Gejl E.D.
RU2194531C2
SYNTHETIC HIV PEPTIDE (VARIANTS), IMMUNOGENIC COMPOSITION FOR INDUCTION OF IMMUNE RESPONSE AGAINST HIV PEPTIDES, DIAGNOSTIC SET FOR ASSAY OF HIV-SPECIFIC ANTIBODIES 1994
  • Sia Charlz D.I.
  • Chong Pele
  • Klejn Majkl Kh.
RU2201421C2
INACTIVATED VACCINES OF RESPIRATORY-SYNTYTIAL VIRUS 1994
  • Sonja E.Sankhuehza
  • Mehri Ehlizabet Ivasishin
  • Michel Genri Klejn
RU2142817C1
RESPIRATORY-SYNCYTIAL VIRUS SUBUNIT VACCINE PREPARATION 1997
  • Kejts Dzhordzh A.
  • Sanuehza Sonja E.
  • Oomen Rajmond P.
  • Klajn Mishel' Kh.
RU2243234C2

RU 2 196 176 C2

Authors

Luzmor Shina M.

Jang Jan-Ping

Chong Pele

Oomen Rejmond P.

Kljajn Mishel' Kh.

Dates

2003-01-10Published

1995-07-21Filed